Mazor Robotics’ stock (NASDAQ:MZOR and TASE:MZOR) has steadily rolled up 260% year-to-date.

Earnings report for Q3 shows a 51% increase in revenue over last year. The Israili-based company develops and markets surgical robots and complementary products. They sold 16 Renaissance systems so far in 2013; the Renaissance is a state-of-the-art mechanical guidance system for spinal surgeries.

Mazor recently filed with the SEC for a $46 million IPO in an ADR offering on NASDAQ with the funds being earmarked to expand the company’s sales and marketing network in the US.